Annual Working Capital
$134.21 M
+$1.66 M+1.25%
31 December 2021
Summary:
Concert Pharmaceuticals annual working capital is currently $134.21 million, with the most recent change of +$1.66 million (+1.25%) on 31 December 2021. During the last 3 years, it has risen by +$1.66 million (+1.25%).CNCE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$139.80 M
-$6.16 M-4.22%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly working capital is currently $139.80 million, with the most recent change of -$6.16 million (-4.22%) on 30 September 2022.CNCE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +1.3% | +38.6% |
| 5 y5 years | -21.7% | +19.1% |
CNCE Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -32.7% | -34.3% |
Concert Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $139.80 M(-4.2%) |
| June 2022 | - | $145.96 M(+46.4%) |
| Mar 2022 | - | $99.69 M(-25.7%) |
| Dec 2021 | $134.21 M(+1.3%) | $134.21 M(+33.0%) |
| Sept 2021 | - | $100.89 M(-18.8%) |
| June 2021 | - | $124.31 M(+7.6%) |
| Mar 2021 | - | $115.55 M(-12.8%) |
| Dec 2020 | $132.55 M(+33.1%) | $132.55 M(+2.7%) |
| Sept 2020 | - | $129.00 M(-11.0%) |
| June 2020 | - | $144.97 M(-6.5%) |
| Mar 2020 | - | $155.12 M(+55.8%) |
| Dec 2019 | $99.59 M(-41.9%) | $99.59 M(-15.1%) |
| Sept 2019 | - | $117.36 M(-14.9%) |
| June 2019 | - | $137.91 M(-10.4%) |
| Mar 2019 | - | $153.87 M(-10.2%) |
| Dec 2018 | $171.40 M(-14.0%) | $171.40 M(-9.2%) |
| Sept 2018 | - | $188.72 M(-7.0%) |
| June 2018 | - | $202.83 M(-4.7%) |
| Mar 2018 | - | $212.89 M(+6.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $199.29 M(+116.2%) | $199.29 M(-1.5%) |
| Sept 2017 | - | $202.23 M(+101.9%) |
| June 2017 | - | $100.15 M(+22.8%) |
| Mar 2017 | - | $81.53 M(-11.5%) |
| Dec 2016 | $92.16 M(-33.0%) | $92.16 M(-10.4%) |
| Sept 2016 | - | $102.87 M(-9.0%) |
| June 2016 | - | $113.08 M(-9.6%) |
| Mar 2016 | - | $125.08 M(-9.0%) |
| Dec 2015 | $137.48 M(+117.9%) | $137.48 M(+1.3%) |
| Sept 2015 | - | $135.74 M(-5.0%) |
| June 2015 | - | $142.81 M(+41.3%) |
| Mar 2015 | - | $101.08 M(+60.2%) |
| Dec 2014 | $63.10 M(+248.1%) | $63.10 M(-13.5%) |
| Sept 2014 | - | $72.93 M(-10.3%) |
| June 2014 | - | $81.32 M(-13.3%) |
| Mar 2014 | - | $93.76 M(+417.2%) |
| Dec 2013 | $18.13 M(-13.4%) | $18.13 M(-33.0%) |
| Sept 2013 | - | $27.05 M(+29.2%) |
| Dec 2012 | $20.94 M(-38.2%) | $20.94 M |
| Dec 2011 | $33.86 M | - |
FAQ
- What is Concert Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual working capital?
The current annual working capital of CNCE is $134.21 M
What is the all time high annual working capital for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual working capital is $199.29 M
What is Concert Pharmaceuticals quarterly working capital?
The current quarterly working capital of CNCE is $139.80 M
What is the all time high quarterly working capital for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly working capital is $212.89 M